Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
230
Zitationen
68
Autoren
2023
Jahr
Abstract
Deep learning (DL) can accelerate the prediction of prognostic biomarkers from routine pathology slides in colorectal cancer (CRC). However, current approaches rely on convolutional neural networks (CNNs) and have mostly been validated on small patient cohorts. Here, we develop a new transformer-based pipeline for end-to-end biomarker prediction from pathology slides by combining a pre-trained transformer encoder with a transformer network for patch aggregation. Our transformer-based approach substantially improves the performance, generalizability, data efficiency, and interpretability as compared with current state-of-the-art algorithms. After training and evaluating on a large multicenter cohort of over 13,000 patients from 16 colorectal cancer cohorts, we achieve a sensitivity of 0.99 with a negative predictive value of over 0.99 for prediction of microsatellite instability (MSI) on surgical resection specimens. We demonstrate that resection specimen-only training reaches clinical-grade performance on endoscopic biopsy tissue, solving a long-standing diagnostic problem.
Ähnliche Arbeiten
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · 111.115 Zit.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · 87.435 Zit.
Global cancer statistics
2011 · 55.018 Zit.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 · 28.982 Zit.
Global cancer statistics, 2012
2015 · 27.328 Zit.
Autoren
- Sophia J. Wagner
- Daniel Reisenbüchler
- Nicholas P. West
- Jan Niehues
- Jiefu Zhu
- Sebastian Foersch
- Gregory Patrick Veldhuizen
- Philip Quirke
- Heike I. Grabsch
- Piet A. van den Brandt
- Gordon Hutchins
- Susan D. Richman
- Tanwei Yuan
- Rupert Langer
- Josien C.A. Jenniskens
- Kelly Offermans
- Wolfram Mueller
- Richard Gray
- Stephen B. Gruber
- Joel K. Greenson
- Gad Rennert
- Joseph D. Bonner
- Daniel Schmolze
- Jitendra Jonnagaddala
- Nicholas J. Hawkins
- Robyn L. Ward
- Dion Morton
- Michel Seymour
- Laura Magill
- Marta Nowak
- Jennifer Hay
- Viktor H. Koelzer
- David N. Church
- David N. Church
- Enric Domingo
- Joanne Edwards
- Bengt Glimelius
- Ismail Gögenür
- Andrea Harkin
- Jen Hay
- Timothy Iveson
- Emma Jaeger
- Caroline Kelly
- Rachel Kerr
- Noori Maka
- Hannah Morgan
- Karin A. Oien
- Clare Orange
- Claire Palles
- Campbell S.D. Roxburgh
- Owen J. Sansom
- Mark Saunders
- Ian Tomlinson
- Christian Matek
- Carol Geppert
- Chaolong Peng
- Cheng Zhi
- Xiaoming Ouyang
- Jacqueline A. James
- Maurice B. Loughrey
- Manuel Salto‐Tellez
- Hermann Brenner
- Michael Hoffmeister
- Daniel Truhn
- Julia A. Schnabel
- Melanie Boxberg
- Tingying Peng
- Jakob Nikolas Kather
Institutionen
- Helmholtz Zentrum München(DE)
- Fresenius (Germany)(DE)
- Technical University of Munich(DE)
- Center for Environmental Health(US)
- Johannes Gutenberg University Mainz(DE)
- University Medical Center of the Johannes Gutenberg University Mainz(DE)
- University of Leeds(GB)
- St James's University Hospital(GB)
- Maastricht University(NL)
- German Cancer Research Center(DE)
- Heidelberg University(DE)
- Johannes Kepler University of Linz(AT)
- Praxis für Humangenetik(DE)
- University of Oxford(GB)
- City Of Hope National Medical Center(US)
- City of Hope(US)
- Technion – Israel Institute of Technology(IL)
- Carmel Medical Center(IL)
- UNSW Sydney(AU)
- The University of Sydney(AU)
- NIHR Surgical Reconstruction and Microbiology Research Centre(GB)
- Cancer Research UK Clinical Trials Unit(GB)
- University of Birmingham(GB)
- University of Zurich(CH)
- University Hospital of Zurich(CH)
- Queen Elizabeth University Hospital(GB)
- University of Glasgow(GB)
- Oxford BioMedica (United Kingdom)(GB)
- Universitätsklinikum Erlangen(DE)
- Comprehensive Cancer Center Erlangen(DE)
- Jinggangshan University(CN)
- Second Affiliated Hospital of Guangzhou Medical University(CN)
- Guangzhou Medical University(CN)
- Queen's University Belfast(GB)
- Belfast Health and Social Care Trust(GB)
- Royal Marsden Hospital(GB)
- National Center for Tumor Diseases(DE)
- King's College London(GB)
- University Hospital Heidelberg(DE)
- RWTH Aachen University(DE)